Atsushi Mizokami Selected Research

Hormones (Hormone)

2/2024	Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
1/2024	Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study.
8/2023	Efficacy of keishibukuryogan for hot flashes in prostate cancer patients receiving androgen deprivation therapy: a sub-analysis focusing on hormonal and cytokine levels.
3/2023	Is it Necessary to Treat all Metastatic Prostate Cancer With Upfront Androgen Receptor Axis-targeted Agents?
12/2022	Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancer.
10/2022	Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men.
6/2022	Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysis.
1/2022	Treatment strategies and outcomes in a long-term registry study of patients with high-risk metastatic hormone-naïve prostate cancer in Japan: An interim analysis of the J-ROCK study.
3/2021	Effectiveness of Vintage Hormone Therapy as Alternative Androgen Deprivation Therapy for Non-metastatic Castration-resistant Prostate Cancer.
1/2021	Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Mizokami Research Topics

Disease

179	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 10/2002
91	Neoplasms (Cancer) 05/2024 - 03/2002
56	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2004
14	Hypogonadism (Hypergonadotropic Hypogonadism) 08/2023 - 09/2009
13	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2005
13	Carcinoma (Carcinomatosis) 01/2024 - 06/2003
11	Renal Cell Carcinoma (Grawitz Tumor) 06/2023 - 05/2006
8	Lower Urinary Tract Symptoms 02/2024 - 03/2011
6	Urologic Neoplasms (Urological Cancer) 02/2024 - 05/2006
5	Non-Muscle Invasive Bladder Neoplasms 05/2024 - 01/2015
5	Disease Progression 08/2023 - 12/2004
4	Residual Neoplasm 05/2024 - 03/2013
4	Hypertension (High Blood Pressure) 08/2023 - 07/2020
4	Sarcopenia 06/2023 - 05/2021
4	Neutropenia 01/2023 - 01/2017
4	Fever (Fevers) 07/2022 - 01/2014
4	Urinary Incontinence 06/2022 - 07/2014
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2021 - 07/2018
3	Hypotension (Low Blood Pressure) 04/2024 - 11/2019
3	Frailty 08/2023 - 10/2022
3	Erectile Dysfunction 08/2023 - 06/2022
3	Hemorrhage 06/2022 - 01/2011
3	Osteoporosis 02/2021 - 09/2017
3	Pain (Aches) 10/2020 - 01/2011
3	Carcinogenesis 03/2019 - 12/2012
3	Breast Neoplasms (Breast Cancer) 02/2017 - 06/2010
2	Bacterial Infections (Bacterial Infection) 02/2024 - 01/2014
2	Adenoma (Adenomas) 01/2024 - 09/2017
2	Hot Flashes 08/2023 - 12/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2023 - 12/2022
2	Neoplasm Micrometastasis 03/2023 - 11/2002
2	Febrile Neutropenia 01/2023 - 04/2013
2	COVID-19 01/2023 - 04/2022
2	Kidney Neoplasms (Kidney Cancer) 11/2022 - 12/2021

Drug/Important Bio-Agent (IBA)

60	AndrogensIBA 01/2024 - 11/2002
36	Prostate-Specific Antigen (Semenogelase)IBA 01/2024 - 10/2002
29	Androgen Receptors (Androgen Receptor)IBA 01/2024 - 11/2002
25	Hormones (Hormone)IBA 02/2024 - 01/2003
25	Testosterone (Sustanon)FDA Link 02/2024 - 09/2009
15	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2011
15	Docetaxel (Taxotere)FDA Link 01/2024 - 04/2013
9	cabazitaxel FDA Link 01/2024 - 01/2017
9	LigandsIBA 11/2022 - 02/2016
9	Proteins (Proteins, Gene)FDA Link 05/2021 - 11/2002
7	CytokinesIBA 08/2023 - 04/2007
6	AcidsIBA 05/2024 - 11/2015
6	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2024 - 07/2013
6	enzalutamideIBA 01/2024 - 05/2016
6	Radium-223IBA 03/2023 - 01/2017
6	CC ChemokinesIBA 11/2022 - 02/2016
6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2016
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 06/2007
6	Diphosphonates (Bisphosphonates)IBA 06/2010 - 10/2005
5	Therapeutic UsesIBA 03/2023 - 05/2019
5	C-Reactive ProteinIBA 12/2022 - 01/2014
5	ChemokinesIBA 08/2021 - 03/2018
5	taxaneIBA 02/2021 - 01/2017
5	Dehydroepiandrosterone (DHEA)IBA 03/2016 - 10/2003
4	Prednisolone (Predate)FDA LinkGeneric 01/2024 - 04/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2011
4	ParaffinIBA 01/2023 - 02/2011
4	pembrolizumabIBA 04/2022 - 03/2021
4	testosterone enanthate (Delatestryl)FDA LinkGeneric 01/2021 - 03/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 11/2002
4	Zoledronic Acid (Zometa)FDA Link 09/2013 - 11/2009
3	abirateroneIBA 01/2024 - 10/2017
3	Small Interfering RNA (siRNA)IBA 04/2023 - 01/2012
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	Abiraterone AcetateIBA 04/2020 - 01/2017
3	VimentinIBA 02/2018 - 03/2017
3	Complementary DNA (cDNA)IBA 01/2017 - 11/2002
3	Dihydrotestosterone (Androstanolone)IBA 06/2016 - 12/2009
3	bicalutamide (Casodex)FDA LinkGeneric 05/2016 - 04/2010
3	Phosphatidylethanolamine Binding ProteinIBA 02/2015 - 02/2006
3	EnzymesIBA 06/2013 - 01/2009
3	Messenger RNA (mRNA)IBA 12/2012 - 12/2004
3	LuciferasesIBA 02/2004 - 12/2003
2	RadiopharmaceuticalsIBA 05/2024 - 03/2023
2	ProcalcitoninIBA 02/2024 - 01/2014
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2024 - 11/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 05/2019
2	keishibukuryoganIBA 08/2023 - 12/2020
2	Chalcone (Benzalacetophenone)IBA 06/2023 - 05/2021
2	AdiponectinIBA 12/2022 - 09/2017
2	Alkaline PhosphataseIBA 12/2022 - 12/2018
2	Hemoglobins (Hemoglobin)IBA 12/2022 - 06/2011

Therapy/Procedure

89	Therapeutics 05/2024 - 10/2002
58	Castration 03/2024 - 04/2010
28	Drug Therapy (Chemotherapy) 01/2023 - 03/2002
19	Radiotherapy 08/2023 - 10/2002
17	Brachytherapy 03/2024 - 02/2006
13	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 07/2003
8	Transurethral Resection of Bladder 05/2024 - 11/2021
7	Nephrectomy 06/2023 - 11/2010
6	Combination Drug Therapy (Combination Chemotherapy) 11/2021 - 01/2005
5	Oral Administration 04/2024 - 11/2015
3	General Anesthesia 04/2024 - 11/2019
2	Cystectomy 02/2024 - 10/2013
2	Nephroureterectomy 01/2024 - 12/2013
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2023 - 05/2021